Methionine residues in proteins are susceptible to oxidation by reactive oxygen species, but can be repaired via reduction of the resulting methionine sulfoxides by methionine-S-sulfoxide reductase (MsrA) and methionine-R-sulfoxide reductase (MsrB). However, the identity of all methionine sulfoxide reductases involved, their cellular locations and relative contributions to the overall pathway are poorly understood. Here, we describe a methionine-R-sulfoxide reduction system in mammals, in which two MsrB homologs were previously described. We found that human and mouse genomes possess three MsrB genes and characterized their protein products, designated MsrB1, MsrB2 and MsrB3. MsrB1 (Selenoprotein R) was present in the cytosol and nucleus and exhibited the highest methionine-R-sulfoxide reductase activity due to presence of selenocysteine (Sec) in its active site. Other mammalian MsrBs contained cysteine in place of Sec and were less catalytically efficient. MsrB2 (CBS-1) resided in mitochondria. It had high affinity for methionine-R-sulfoxide, but was inhibited by higher concentrations of the substrate. The MsrB3 gene gave rise to two protein forms, MsrB3A and MsrB3B. These were generated by alternative splicing that introduced contrasting N-terminal and C-terminal signals, such that MsrB3A was targeted to the endoplasmic reticulum and MsrB3B to mitochondria. We found that only mitochondrial forms of mammalian MsrBs (MsrB2 and MsrB3B) could compensate for MsrA and MsrB deficiency in yeast. All mammalian MsrBs belonged to a group of zinccontaining proteins. The multiplicity of MsrBs contrasted with the presence of a single mammalian MsrA gene as well as with the occurrence of single MsrA and MsrB genes in yeast, fruit flies and nematodes. The data suggested that different cellular compartments in mammals maintain a system for repair of oxidized methionine residues and that this function is tuned in enzyme-and stereo-specific manner.
INTRODUCTION
Methionine sulfoxide reductases catalyze reduction of free and protein-bound methionine sulfoxides to corresponding methionines (Brot et al., 1981; Weissbach et al., 2002) . The oxidation of methionine by reactive oxygen species (ROS) generates a diastereomeric mixture of methionine-S-sulfoxide (Met-S-SO) and methionine-R-sulfoxide (Met-R-SO). Two distinct enzyme families evolved for reduction of these sulfoxides, with methionine-S-sulfoxide reductase (MsrA) being stereospecific for Met-S-SO and methionine-R-sulfoxide reductase (MsrB) for Met-R-SO. Previously proposed functions of these enzymes include repair of oxidativelydamaged proteins, regulation of protein function and elimination of oxidants through reversible formation of methionine sulfoxides (Levine et al., 2000) .
Recently, MsrB proteins have been identified and characterized in various organisms
including bacteria (Grimaud et al., 2001; Olry et al., 2002; Etienne et al., 2003) , yeast (Kryukov et al., 2002; Koc and Gladyshev, unpublished data) , fruit fly , and mammals (Jung et al., 2002; Kryukov et al., 2002; Moskovitz and Stadtman, 2003) . To date, two mammalian MsrB proteins have been identified: selenocysteine (Sec)-containing protein, designated selenoprotein R (SelR) (Kryukov et al., 1999 (Kryukov et al., , 2002 and its homolog, designated CBS-1, in which Cys is present in place of Sec (Jung et al., 2002) . The Sec-containing MsrB has only been described in mammals. Members of the MsrB family have been characterized mechanistically Olry et al., 2002) and structurally .
However, what is the number of methionine sulfoxide reductases that are present in various organisms and what their cellular locations and relative contributions are to the overall pathway are not known.
For recoding UGA as a Sec codon, several trans-acting elements are employed, including a unique tRNA Sec and a Sec-specific elongation factor SelB. In eukaryotes, the SelB function is served by two proteins, elongation factor EFSec and a SECIS-binding protein SBP2 (Atkins and Gesteland, 2000) . In addition to these factors, a cis-acting stem-loop structure within selenoprotein mRNA, designated selenocysteine insertion sequence (SECIS) element, is required for Sec insertion. Eukaryotic SECIS elements are located in 3' untranslated regions of selenoprotein genes (Hatfield and Gladyshev, 2002) , whereas bacterial SECIS elements are present within selenoprotein ORFs, immediately downstream of the Sec-encoding UGA codon (Zinoni et al., 1990; Sandman and Noren, 2000) . Recent studies on the Escherichia coli SelB and formate dehydrogenase H SECIS element revealed that (i) only the upper stem-loop structure with a proper distance from UGA is required for Sec incorporation, and (ii) a GpU sequence at the tip of the apical loop and a bulged uracil that is located five Watson-Crick base-pairs upstream of the GpU motif are essential for Sec insertion in E. coli (Liu et al., 1998; Fourmy et al., 2002) . However, the overall bacterial consensus SECIS element is not known.
In the present study, we identified a new MsrB gene in mammals and characterized products of three mammalian MsrBs genes with respect to catalytic functions, cellular locations and alternative splicing variants. The data suggest that various cellular compartments in mammals maintain systems for repair of oxidized methionines and that this function is tuned in enzymeand stereo-specific manner.
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MATERIALS AND METHODS
Preparation of Recombinant Mammalian MsrB Proteins
The cDNA for Cys mutant of mouse MsrB1 (mSelR) (Kryukov et al., 2002) MsrB3A), was made by inserting the corresponding cDNA into pET21a. This construct coded for a protein with a C-terminal His tag. All constructs were verified by DNA sequencing. MsrB proteins were expressed in E. coli, purified using TALON metal affinity resin (Clontech) and analyzed for purity by SDS-PAGE. Protein concentration was determined by the Bradford method using bovine serum albumin as a standard.
Preparation of Sec-Containing MsrB1
To express a recombinant Sec-containing MsrB1 in E. coli (Sec in the amino acid position 95 is encoded by UGA), we mutated sequences within the ORF downstream of UGA to generate a bacterial SECIS element. The SECIS element was designed to introduce as few mutations as possible in the protein sequence, yet to build a functional SECIS element. To avoid the contamination of the full-length Sec-containing MsrB1 with the truncated form, in which the UGA codon designates termination of translation, we also introduced a His tag at the C-terminus To prepare the recombinant MsrB1-Sec/SECIS, E. coli BL21(DE3) cells harboring pMR1-SECIS4 were grown in 18 L of LB medium supplemented with 2 µM Na 2 SeO 3 and 100 µg/ml ampicillin at 37ºC to A 600 = 0.6, induced with 0.1 mM IPTG at 30ºC for 6 h, and harvested by centrifugation. The harvested cells were resuspended in an extraction buffer (50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 15 mM imidazole, 1 mM PMSF) and treated by sonication.
After removal of insoluble material by centrifugation, the supernatant was applied to a TALON metal affinity column (Clontech). The protein was eluted with an elution buffer containing 100 mM imidazole, 50 mM sodium phosphate, pH 7.5, 50 mM NaCl. Due to small amounts of the affinity purified Sec-containing protein, protein concentration was determined by western blotting using MsrB1-Cys as an internal standard, followed by analysis of the western signals with a densitometer.
Determination of Methionine Sulfoxide Reductase Activity and Analysis of Enzyme Kinetics
Methionine sulfoxide reductase activity was assayed using dabsylated L-Met-SO or free L-Met-SO as a substrate. The assay for the reduction of dabsyl-Met-SO to dabsyl-Met was performed as described previously . Briefly, the reaction mixture (100 µl) contained 50 mM sodium phosphate (pH 7.5), 20 mM DTT, 200 µM dabsyl-Met-R or S-SO, and 7 0.1-25 µg of purified proteins. The reaction was carried out at 37ºC for 30 min, and stopped by adding 200 µl of acetonitrile. The reaction product, dabsyl-Met, was analyzed by HPLC as described previously . A typical reaction mixture (100 µl) for reduction of free Met-SO to Met contained 50 mM sodium phosphate (pH 7.5), 20 mM DTT, 1 mM free Met-R-SO, and 5-50 µg of purified proteins. The reaction was carried out at 37ºC for 2 h. Thin layer chromatography (n-butanol:acetic acid:water 60:15:25) was used to identify Met as the reaction product. The Met was detected using ninhydrin spray.
All kinetic constants in this paper were determined using dabsyl-Met-R-SO as a substrate.
K m and k cat values were determined using Lineweaver-Burk plots.
Different diastereomers of Met-SO were prepared as described (Lavine, 1947) . Dabsyl derivatives of Met, Met-R-SO, and Met-S-SO were also prepared as described (Minetti et al., 1994) .
Determination of Zinc Content
Zinc content of MsrB proteins was analyzed using inductively coupled argon plasma (ICAP) at the Chemical Analysis Laboratory of University of Georgia. Simultaneously, 19 other trace elements were analyzed, but these did not show significant levels. In addition, buffers against which MsrBs were dialyzed for metal analysis, were assayed in parallel, and these showed no significant zinc concentrations.
Expression of MsrB Proteins in Saccharomyces cerevisiae
The constructs for expression of MsrB proteins in yeast were made using a yeast expression vector p423 GPD (Mumberg et al., 1995 (Kryukov et al., 2002) , and transformants were selected for histidine prototrophy. Cells containing p423 only or plasmids with MsrB genes were grown in yeast nitrogen base (YNB) minimal medium at 30ºC.
Constructs for Subcellular Localization
Green fluorescent protein (GFP) expression constructs described in this work were prepared using pEGFP-N1 ( 
Fluorescence Confocal Microscopy
Transfections into CV-1 cells with appropriate constructs were performed using Lipofectamine (Invitrogen). MsrB1 was stained with anti-MsrB1 antibodies, followed by secondary anti-rabbit Cy5 (Jackson ImmunoResearch Laboratories). Mitochondria were stained with MitoTracker Red (Molecular Probes). ER was stained with Calregulin (C-17) (Santa Cruz Biotechnology) followed by secondary anti-goat Cy5 (Jackson ImmunoResearch Laboratories).
Images were collected using a BioRad MRC1024ES laser scanning microscope.
RESULTS
Identification of a New Mammalian MsrB Gene
Two mammalian MsrB protein forms have been recently identified, including selenoprotein R (also designated as selenoprotein X and most recently as MsrB) and its homolog designated CBS-1 (Huang et al, 1999; Kryukov et al., 1999; Lescure et al., 1999; Jung et al., 2002; Kryukov et al., 2002) . By homology searches of NCBI non-redundant and EST databases using these known MsrB sequences, we identified a new mammalian MsrB gene. The new MsrB sequences were identified in human, mouse and rat genomes. No additional MsrB homologs were detected, suggesting that mammalian genomes code for three MsrB genes. Here, we designate selenoprotein R as MsrB1, CBS-1 as MsrB2 and the newly identified MsrB homolog as MsrB3.
Analysis of human EST sequences corresponding to MsrB3 revealed two cDNA forms that differed in their 5' sequences. One form coded for an ORF of 192 residues and was designated as MsrB3A; the second coded for an ORF of 185 residues and was designated as MsrB3B ( Figure 1A ). Both coding sequences were identical except in their N-terminal regions.
Analysis of the human MsrB3 gene structure revealed that these two forms were generated by alternative splicing ( Figure 1B ). The 184-kb human MsrB3 gene was located on chromosome 12
and contained 8 exons. Human MsrB1 and MsrB2 genes had 5 exons each, were of considerably smaller size, and were located on chromosomes 16 and 10, respectively.
MsrB3 showed 22% identity to MsrB1 and 39% identity to MsrB2. Like MsrB2, it had a conserved catalytic Cys residue (Cys158, numbering follows MsrB3A sequence), which corresponded to the catalytic Sec95 in MsrB1. In addition, the protein had conserved Asp148 and Arg156, the residues that were predicted to activate the nucleophilic group at the catalytic Cys (or Sec) and together with this thiolate (or selenolate) to form a catalytic triad .
A Cys residue that was shown to function in thiol-disulfide exchange through formation of a disulfide bond with the active site Cys residue (this residue is conserved in at least 50% of known 
MsrB3 Stereospecifically Reduces Met-R-SO
To test whether MsrB3, like previously characterized MsrBs, reduces specifically the Met-R-SO stereoisomer to Met, we prepared a full-length recombinant MsrB3A, that lacked the first 31 residues (this protein corresponded to signal-less MsrB3A or MsrB3B) and a full-length MsrB3B using the pET21a expression vector. We found that the growth of E. coli 
Preparation of Sec-Containing MsrB1
To address how the Sec residue in MsrB1 affects its enzyme activity and to compare enzymatic characteristics of mammalian MsrBs, we expressed the recombinant Sec-containing MsrB1 (MsrB1-Sec/SECIS) in E. coli. The MsrB1 gene has a mammalian SECIS element in its 3'-UTR, however a bacterial Sec insertion system is different from that of mammals. Specifically, We generated various versions of a bacterial SECIS element downstream of the UGA codon (codon position 95) by site-directed mutagenesis (Figure 2 ) such that the downstream coding sequences had 2, 3 or 4 mutated residues. In each construct, the protein was designed to contain a C-terminal His tag. This allowed us to separate, using affinity chromatography, the full length protein from the truncated form, in which the UGA terminated protein synthesis. Previous studies indicated that Sec insertion into recombinant mammalian selenoproteins in E. coli was inefficient and the major protein products were truncated proteins (Arner et al, 1999) . We found that most mutations downstream of the UGA resulted in either low efficiency of Sec insertion or in completely insoluble proteins. The truncated form of MsrB1, in which the UGA codon was used as a stop signal, was also insoluble.
However, we were able to obtain a soluble and functional Sec-containing protein (MsrBSec/SECIS) by introducing a SECIS element with concomitant changes in four residues in MsrB1: Ser99Arg, Ser100Leu, Lys102Gly, and Phe103Pro. We also prepared a Cys mutant of MsrB-Sec/SECIS (MsrB1-Cys/SECIS) as well as a Cys mutant of the wild type MsrB1 (MsrB1-Cys), which served as controls in determining whether mutations of the 4 residues affected the catalytic activity of the enzyme.
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Catalytic Properties of Mammalian MsrBs -Key Role of Sec in MsrB1
Table 1 summarizes the specific activities and enzyme kinetics of mammalian MsrBs using dabsyl-Met-R-SO as substrate. MsrB1-Sec/SECIS exhibited the highest specific activity.
The specific activity of MsrB1-Cys/SECIS was similar to that of MsrB1-Cys (Cys mutant of the wild type enzyme), suggesting that mutation of the four residues to generate the SECIS element did not alter the enzyme activity. The specific activity of MsrB1-Sec/SECIS was ~800-fold higher than those of the two Cys mutants, MsrB1-Cys/SECIS and MsrB1-Cys, indicating that high activity of MsrB was due to the presence of Sec. Furthermore, MsrB1-Sec/SECIS showed about 4-fold higher specific activity than MsrB2 and MsrB3. Bar-Noy and Moskovitz recently reported that a recombinant Sec-containing MsrB1, in which 6 residues were mutated downstream of Sec, had 100-200 fold higher specific activity than the Cys mutant (Bar-Noy and Moskovitz, 2002) .
Further kinetic characterization of mammalian MsrBs revealed that MsrB2 was inhibited by concentrations of dabsyl-Met-R-SO over 300 µM (Figure 3 ). In contrast, no substrate inhibition was observed for MsrB1 and MsrB3 up to the highest tested substrate concentration (3.2 mM).
K m values for dabsyl-Met-R-SO were 1.0 mM for MsrB1-Sec/SECIS, 0.9 mM for MsrB1-Cys/SECIS, 1.1 mM for MsrB1-Cys, 0.17 mM for MsrB2, and 2.9 mM for MsrB3. These data, along with the finding of substrate inhibition, suggested that MsrB2 is adapted to work with low concentrations of methionine sulfoxide, whereas MsrB1 and MsrB3 are most active at higher concentrations of the substrate. The K m values of MsrB1 and MsrB3 were similar to that of Drosophila MsrB (K m value of 2.1 mM) .
The k cat value of MsrB1-Sec/SECIS (2.28 s -1 ) was similar to that of MsrB3 (2.29 s -1 ), but 80-fold and 10-fold higher than that of the corresponding Cys mutant and MsrB2, respectively.
Moreover, the catalytic efficiency, k cat /K m , of MsrB1-Sec/SECIS was the highest of all tested
MsrBs: approximately 80-fold, 2-fold, and 3-fold higher than those of its Cys mutant, MsrB2, and MsrB3, respectively. These data revealed that the high catalytic efficiency of MsrB1-Sec/SECIS was due to Sec, which increased catalytic activity without significantly affecting substrate binding. Thus, it appears that selenium provides a key contribution to the MsrB activity in mammalian cells.
Mammalian MsrBs Reduce Free Met-R-SO
Although MsrB and MsrA isolated from various sources catalyze reduction of protein methionine sulfoxides, they are also known to have low activity with free methionine sulfoxides.
Therefore, we also assayed for free Met-R-SO reductase activity of mammalian MsrBs. As shown in Figure 4 , all three MsrBs have the ability to reduce free Met-R-SO to Met.
Mammalian MsrBs are Zinc-Containing Enzymes
MsrB1 is a zinc-containing enzyme (Kryukov et al., 2002) . Recent study demonstrated that zinc was essential for the catalytic function of Drosophila MsrB and that it was coordinated in the enzyme through four cysteine residues organized in two CxxC motifs .
However, these residues were absent in a number of bacterial MsrBs, apparently because they were lost during evolution. It was proposed that zinc serves a structural role and is not involved directly in catalytic reaction . Primary sequences of MsrB2 and MsrB3 conserved the two CxxC motifs, suggesting that these enzymes also contained zinc. We analyzed the content of 20 trace elements in dialyzed preparations of MsrB2 and MsrB3. Only zinc was detected in significant amounts: 0.36 equivalents in MsrB2 and 0.61 equivalents in MsrB3. Thus, all three mammalian MsrBs are zinc-containing proteins.
In an attempt to remove zinc from the enzymes, MsrB1-Cys, MsrB2, or MsrB3 were incubated with 5 mM EDTA or 5 mM CDTA (a stronger chelating agent) at 4°C for 1 h, and then dialyzed against a buffer containing 50 mM sodium phosphate (pH 7.5) and 50 mM NaCl.
However, the treatment with either EDTA or CDTA did not affect the enzyme activity of any of three MsrBs, suggesting that zinc was strongly bound in these enzymes. A similar strong binding of the metal was previously observed in Drosophila MsrB . We further examined whether in the presence of zinc, the enzyme activity of MsrBs may be increased and found that it was not affected by the addition of 0.1 mM ZnCl 2 . However, at higher concentration (1.0 mM ZnCl 2 ), we observed 25-50% inhibition of MsrB1-Cys and MsrB2 activities.
Expression of Mammalian MsrB Proteins in Yeast
To 
MsrB1 is a Nuclear and Cytosolic Protein
To investigate subcellular distribution of mammalian MsrBs, we generated various GFPfusion constructs using a pEGFP-N1 vector (Figure 6 ). In the case of MsrB1, its cysteine mutant was used. The constructs were transfected in the monkey kidney CV-1 cells. The MsrB1-GFP protein was localized in the cytoplasm and also in the nucleus ( Figure 7A ). However, nuclear location of MsrB1-GFP could have been due to GFP, which is partially enriched in the nucleus when expressed by itself. To examine whether MsrB1 is present in the nucleus, we generated an MsrB1∆GFP construct, which encoded only a cysteine mutant of MsrB1. As shown in Figure 7B , MsrB1 was present in both nucleus and cytoplasm. Although MsrB1 does not have a pronounced nuclear localization signal, it is rich in positively charged residues, which could serve to transfer the protein in the nucleus.
MsrB2 is Targeted to Mitochondria
MsrB2 contained a typical predicted mitochondrial signal at the N-terminus (MARLLRALRGLPLLQAPGRLARG). As shown in Figure 8 , both S2-GFP (the N-terminal signal peptide of MsrB2 fused to GFP) and MsrB2-GFP (the full length MsrB2 fused to GFP) colocalized with mitochondria, whereas MsrB2∆S-GFP (MsrB2 lacking the signal peptide and fused to GFP) exhibited cytoplasmic and nuclear location. Interestingly, the fluorescence in some cells transfected with S2-GFP or MsrB2-GFP constructs was detected in the cytoplasm and the nucleus. However, western blots with anti-GFP antibodies revealed that a 26 kDa band corresponding to the GFP protein was detected besides the MsrB2-GFP fusion protein in MsrB2-GFP transfected cells (data not shown). It appears that this GFP contributed to the nonmitochondrial location of the GFP fluorescence. The data suggested that the GFP was either produced by cotranslation (even though the ~600 bp MsrB2 fragment was present upstream of the possible ATG initiation codon of GFP) or the expressed MsrB2-GFP fusion protein was partially cleaved to generate GFP.
MsrB3A Resides in the ER and MsrB3B in Mitochondria
The primary sequence of MsrB3 contained a KAEL tetrapeptide at the C-terminus, an analog of the classical ER retention signal, the KDEL sequence. Furthermore, MsrB3A contained a typical secretory signal peptide at the N-terminus, whereas MsrB3B had a different signal peptide. To determine the subcellular distribution of MsrB3A and MsrB3B, we employed a set of constructs that encoded various fusion proteins between GFP and MsrB3 ( Figure 6 ). We first tested whether MsrB3A or MsrB3B are located in the ER (Figure 9 ). The S3A-GFP-MsrB3 (GFP inserted between the predicted ER signal and the rest of MsrB3) co-localized with the ER marker.
However, the GFP-MsrB3 (a fusion protein that lacked the signal peptide) was not detected in the ER and instead was seen in the cytoplasm. Likewise, S3A-GFP (a protein with the N-terminal signal peptide fused to GFP) was not present in the ER. To test whether the tetrapeptide KAEL functioned as an ER retention signal, we developed a construct that encoded S3A-GFPMsrB3∆KAEL (a fusion protein with the deletion of KAEL). This protein was not localized in the ER. These data demonstrated that the ER location of MsrB3A was dependent on the tetrapeptide KAEL sequence.
In contrast to the ER location of MsrB3A, MsrB3B was not seen in this compartment when the corresponding fusion proteins were expressed in CV-1 cells, even though MsrB3B also had the KAEL retention signal. As shown in Figure 9 , S3B-GFP-MsrB3 and S3B-GFP proteins did not co-localize with the ER standard. Similar data were obtained with S3B-GFPMsrB3∆KAEL. Instead, the fluorescence from these fusion proteins co-localized with
MitoTracker, a mitochondrial standard. As shown in Figure 10 , S3B-GFP and S3B-GFP-MsrB3
were observed in the mitochondria, whereas GFP-MsrB3 did not show mitochondrial location.
Thus, MsrB3A was present in the ER due to its N-terminal and C-terminal signals. Although
MsrB3B also had the C-terminal ER retention signal, its N-terminal signal peptide targeted this protein to mitochondria.
DISCUSSION
We identified a third MsrB gene in mammals and characterized kinetic properties, subcellular distribution and alternative splicing forms of three methionine-R-sulfoxide reductases.
Our data revealed that methionine sulfoxide reduction in mammals occurs in different cellular compartments and is fine-tuned in enzyme-and stereo-specific manner.
The newly identified MsrB3 is unusual in that it occurs in two protein forms, MsrB3A
and MsrB3B. Genomic analyses revealed that these forms are generated by alternative first exon splicing and differ in their N-terminal sequences.
The first mammalian MsrB identified was selenoprotein R, in which the position of the active site Cys residue is occupied by Sec. Substitution of Sec with Cys decreased the enzyme activity ~800-fold, indicating the essential role of Sec in this enzyme. On the other hand, the specific activity of Cys mutants of MsrB1 was ~170-fold and ~210-fold lower than that of MsrB2 and MsrB3, respectively, suggesting that the other mammalian MsrBs were tuned for the use of Cys. The Sec-containing MsrB1 had ~4-fold higher specific activity than MsrB2 and MsrB3.
Thus, MsrB1 appears to be the major MsrB in mammalian cells and, together with MsrA, it contributes significantly to the reduction of methionine sulfoxides. Whether a single MsrA gene can generate multiple protein products that are targeted to different cellular compartments is not known. Recent reports provided evidence that MsrA was present in mitochondria and cytosol Vougier et al., 2003) . However, this protein has neither an ER signal peptide nor a C-terminal ER retention signal, and whether it resides in the nucleus is also not known. Enzyme activity was determined using dabsyl-Met-R-SO as described in Materials and Methods.
The purified MsrB3∆(1-31) lacking the N-terminal signal peptide was used as MsrB3. The 
